Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
Quick Stats
62.2
AI Score
BUY0.2
Volume Ratio
Next Earnings
14
+ve Days (30d)
15
-ve Days (30d)
QGEN Stock Summary
Last updated Jan 27, 2026
QGEN is currently trading at $52.5, positioned below its 200-day moving average of $, suggesting bearish momentum. The stock has a 52-week range of $37.63 to $57.815.
Technical Analysis: The 50-day moving average stands at $, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 67.846, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.369, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates QGEN at 62.2/100 with a BUY recommendation.
QGEN (QIAGEN N.V.) Indicators
Last updated Jan 27, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 67.846 |
| CMF (20) | 0.369 |
| ROC (10) | 14.751 |
| ADX (14) | 37.662 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 2.281 |
| AROONOSC (14) | |
| WILLAMS %R (14) | -30.609 |
| MFI (14) | 70.109 |
QGEN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
QGEN Price vs Max Options Open Interest
QGEN Max Change In Options Open Interest
QGEN Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
QGEN Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
QGEN Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
QGEN Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
QIAGEN N.V. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
QGEN Moving Averages Analysis
QGEN (QIAGEN N.V.) Simple Moving Averages
Moving Averages are last updated
| Days | MA |
|---|
QGEN Fundamental Analysis
| P/E (Forward) | 19.0476 |
| P/E (Trailing) | 27.5231 |
| Market Cap ($) | 11.1 billion |
| Earnings/Share ($) | 1.95 |
| Net Proft Margin (%) | 0.1958 |
| Dividend/Share ($) | 0.263 |
| EPS Estimate Current Year ($) | 2.4808 |
| EPS Estimate Next Year ($) | 2.6352 |
| WallStreet Target Price ($) | 53.0972 |
| Most Recent Quarter |